BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 9:55:00 AM | Browse: 608 | Download: 710
Publication Name World Journal of Gastroenterology
Manuscript ID 2008
Country/Territory Türkiye
Received
2013-01-20 19:13
Peer-Review Started
2013-01-21 15:55
To Make the First Decision
2013-02-21 18:30
Return for Revision
2013-02-25 16:12
Revised
2013-03-25 20:08
Second Decision
2013-04-09 20:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-04-10 07:51
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-05-16 18:34
Publish the Manuscript Online
2013-05-20 14:33
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Wei Sun, Wei-Wei Dong, Lin-Lin Mao, Wen-Mei Li, Jian-Tao Cui, Rui Xing and You-Yong Lu
Funding Agency and Grant Number
Corresponding Author Rui Xing, PhD, Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital/Institute, No. 52 Fucheng Road, Haidian District, Beijing 100142, China. sherry19820420@hotmail.com
Key Words p42.3; Hepatocellular carcinoma; HepG2; Overexpression; Tumorigenicity
Core Tip p42.3 is a novel tumor-specific and mitosis phase-dependent expression gene. It is believed to be involved in tumorigenesis in gastric and colorectal cancer. To the best of our knowledge, this is the first study to investigate the expression and function of p42.3 in hepatocellular carcinoma (HCC). We found that p42.3 promotes tumorigenicity and tumor growth in HepG2 cells and is overexpressed in HCC. These results suggest that p42.3 may act as a novel tumor biomarker and aid in the development of improved therapeutic strategies.
Publish Date 2013-05-20 14:33
Citation Adas G, Adas M, Arikan S, Sarvan AK, Toklu AS, Mert S, Barut G, Kamali S, Koc B, Tutal F. Effect of growth hormone, hyperbaric oxygen and combined therapy on the gastric serosa. World J Gastroenterol 2013; 19(19): 2904-2912
URL http://www.wjgnet.com/1007-9327/full/v19/i19/2904.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i19.2904
Manuscript File 2008-Review.doc
Answering Reviewers 2008-Answering reviewers.doc
Copyright License Agreement 2008-Copyright assignment.pdf
Institutional Review Board Approval Form or Document p42.3 ethics certification.pdf
Non-Native Speakers of English Editing Certificate 2008-Language certificate.pdf
Peer-review Report 2008-Peer review(s).pdf
Scientific Editor Work List 2008-Scientific editor work list.doc